Mahdieh Khazaee - Immunology Research Center, BuAli Research Institute, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahdi Taheri Bonakdar - Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahmoud Ebrahimi - Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Reza Aarpazhooh - Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamideh Ghazizadeh - International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohsen Mouhebati - Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Maryam shahi - Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Fatemeh Haji shamsaei - Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Zahra Alizadeh hassani - Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Faezeh Ghasemi - Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad,Iran.
Maryam Tayefi - Norwegian Center for E-Health Research, University Hospital of North Norway, Tromsø, Norway.
Shima Tavallaie - Department of Biochemistery and Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Amirhosein Sahebkar - Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Gordon A. Ferns - Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN۱ ۹PH, UK.
Seyed Mohammad Reza Parizadeh - Metabolic Syndrome Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Majid Ghayour-Mobarhan - International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Introduction: An association between heat shock protein ۲۷ (Hsp۲۷) antigen with cardiovascular risk factors has been shown previously. Furthermore, higher levels of serum anti-HSP۲۷ antibodies are also related to higher cardiovascular morbidity and mortality. In the current study, we looked at the relationship between serum Hsp۲۷ antibodies and hypertension, as an important cardiovascular risk factor, in individuals without evidence of cardiovascular disease (CVD).Methods: A sub-population of hypertensive patients (HTN+) without underlying CVD were recruited from the Mashhad stroke and atherosclerosis heart disease (MASHAD) study to assess the association between serum Hsp۲۷ antibodies and hypertension; independent of other cardiovascular risk factors. A total of ۱۵۹۹ people were studied of whom ۲۸۸ individuals had hypertension and ۱۳۱۱ were used as controls (HTN-).Results: Mean serum Hsp۲۷ antibody titers were ۰.۲۰ (۰.۲۷) OD in the whole population sample and was not significantly different in the normotensive (HTN-) compared to HTN+ individuals with different degrees of hypertension.Conclusion: There were no significant associations between serum anti-Hsp۲۷ concentrations and either the presence or severity of hypertension. Future studies are warranted to explore the association of anti-Hsp۲۷ antibody and antigen levels and other cardiovascular risk factors.

Heat shock protein ۲۷ antibody, Hypertension, Cardiovascular Disease